期刊文献+

高效液相色谱-质谱联用测定人血浆中氯雷他定 被引量:2

Determination of loratadine in human plasma by HPLC-MS/MS
原文传递
导出
摘要 目的:建立高效液相色谱-质谱联用法测定人血浆中氯雷他定浓度。方法:分析柱为Gemini C18(5μm,50 mm×2.0mm),流动相为0.2%甲酸水溶液-甲醇(33.5∶66.5,v/v),流速:0.2 mL.min-1,柱温:25℃。采用四级杆质谱检测器电喷雾离子化(ESI)源,检测方式为正离子多离子反应监测(SRM)。结果:线性范围为0.2~25.6μg.L-1,平均提取回收率68.7%,日间RSD小于13.78%,日内RSD小于6.16%。结论:该方法快速、灵敏、重现性好,可用于临床血药浓度监测和药动学研究。 OBJECTIVE To establish a method for determination of loratadine in human plasma by HPLC-MS/MS.METHODS Using Gemini C18(5 μm,50 mm×2.0 mm)column,0.2% methanoic acid solution-methyl-alcohol(33.5:66.5)were served as mobile phase with 0.2 mL·min-1 flow rate.A surveyor TSQ quantum equipped with an at mospheric pressure ESI source was detector and was operated in positive ion SRM.RESULTS The linear ranges were 0.2-25.6 μg·L-1.The average recovery was 68.7%.The relative standard deviations of inter-day were less than 13.78% and intra-day were less than 6.16%.CONCLUSION The method is rapid,sensitive,reproducible.It was suitable for therapeutic drug monitoring and pharmacokinetic study.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第18期1516-1519,共4页 Chinese Journal of Hospital Pharmacy
关键词 氯雷他定 高效液相色谱-质谱 血药浓度 loratadine HPLC-MS/MS plasma concentration
  • 相关文献

参考文献5

二级参考文献25

  • 1ZHONG DF, Blume H. HPLC - determination of loratadine and its active metabolite descarboethoxyloratadine in human plasma. Pharmazie, 1994,49( 1 ) :736.
  • 2Sutherland FCW, de Jager AD, Badenhorst D, et al. Sensitive liquid chromatography- tandem mass spectrometry method for the determination of loratadine and its major active metabolite decarboethoxyloratadine in human plasma. J Chromato~r A .2001.914:37.
  • 3Martens J. Determination of loratadine and pheniramine from human serum by gas chromatography - mass spectrometry. J Chromatogr B,1995,673 : 183.
  • 4Simons FER,Simons KJ. Clinical pharmacology of new histamine H1 receptor antagonists. Clin Pharrnacokinet , 1999,36:346.
  • 5Kunicki PK. Determination of loratadine in human plasma by highperformance liquid chromatographic method with uhraviolet detection.J Chromatogr B,2001,755:331.
  • 6Pawel K. Kunicki Determination of loratadine in human plasma by high-performanceliquid chromatographic method with ultraviolet detection [J]. Journal of Chromatography B, 2001,755: 331.
  • 7James Hilbert, Elaine Radwanski, Bay Weglein, et al. Pharmacokinetic and dose proportionality of loratadine [J]. J Clin Pharmacol, 1987, 27: 694.
  • 8Simons FER,Simons KJ. Clinical of pharmacology of new histamine H1 receptor antagonists[J]. Chin Pharmacokinet,1999,36:346 -347.
  • 9Sora DI, Udrescu S, David V, et al .Validated ion pair liquid chromatography/ fluorescence detection method for assessing the variability of the loratadine metabolism occurring in bioequivalence studies[J ] .Biomed Chromatogr ,2007,21(10) : 1 023.
  • 10Noehr-Jensen L, Bidstrup TB, Nielsen F. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers[J] .Eur J Clin Pharmacol, 2006, 62(6) : 4:37.

共引文献18

同被引文献196

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部